QualityStocksNewsBreaks Archives - Page 710 of 1390

WednesdayMar 10, 2021 11:17 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Leverages ‘Absolute Powerhouse Compound’ as IND Status Paves Way for Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco, in a recent podcast, showed his excitement at news that the U.S. Food and Drug Administration (“FDA”) had granted Berubicin investigational new drug (“IND”) status. The IND designation clears the way for the company to start human clinical trials and to ship the experimental drug across state lines to clinical investigators. “This is the biggest news we’ve announced since our IPO back in November 2019,” Climaco said of the significant milestone. “Based on that IND approval, we expect, in the next 90 to 120 days, we will go from zero active clinical trials…

WednesdayMar 10, 2021 11:10 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Emerging Growth Virtual Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual Maxim Group Emerging Growth Virtual Conference. The two-day conference is slated for March 17–18, 2021. During the online event, all registered attendees will be able to access Sapirstein’s presentation on demand. The presentation will include an overview of AzurRx BioPharma, including its business and clinical-development programs; Sapirstein will also talk about goals and accomplishments the company is working toward in 2021. Following the presentation, Sapirstein and other members of the AzurRx management team will…

WednesdayMar 10, 2021 10:38 am

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Host Q4 and Full-Year 2020 Results Conference Call

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that it will hold a conference call to discuss its results for the four quarter and year ended December 31, 2020. The call, to be hosted by Sigma Labs president and CEO Mark Ruport and CFO Frank Orzechowski, is scheduled to take place at 4:30 p.m. Eastern Time on Wednesday, March 24, 2021, followed by a question-and-answer period. Interested parties can access the call by dialing 1-877-407-9039 (Toll-Free) or 1-201-689-8470 (International) and entering conference ID: 13717059. The conference call will…

WednesdayMar 10, 2021 10:38 am

QualityStocksNewsBreaks – Mobius Interactive Inc. Announces Appointment of New VP with Deep Investor Relations, Corporate Development Expertise

Mobius Interactive has appointed a new vice president and board member. Effective immediately Seamus Byrne will take over his new responsibilities, bringing his extensive insight and expertise to bear as he focuses on helping the nascent company achieve its mission. Byrne has more than three decades of capital market experience in both the private and public sectors, gathering a wealth of corporate development knowledge and insight along the way. He has led the development and operations of several different organizations and has played a key role in raising more than C$100 million; he has also driven market capitalizations for public…

WednesdayMar 10, 2021 10:11 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Resignation of Outside Director

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, today announced the resignation of John M. Hollister. Hollister served as the company’s CEO prior to its reverse acquisition by Grapefruit Boulevard Investments as well as its transition from a developer of 3D imaging to a fully licensed manufacturer and distributor of cannabis products. These include Grapefruit’s patented, disruptive Hourglass(TM) time-release THC/cannabinoid delivery cream. “We are pleased that the previous chapter of the Imaging3/Grapefruit saga has come to an amicable conclusion. While we, of course, will devote the vast majority of our time and energy to our rapidly growing…

WednesdayMar 10, 2021 9:57 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announced Partner Has Received ISO Certification for Rapid COVID-19 Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has announced that 3a-diagnostics GmbH ("3a") has received EN ISO 13485 certification for its rapid point-of-care, SARS-CoV-2 RT-PCR Test System ("Covid-ID Lab"). 3a-diagnostics is XPhyto’s exclusive German diagnostics development partner. In addition the company expects CE-IVD approval for the product this month. These two approvals will allow 3a-diagnostics GmbH to distribute the Covid-ID Lab. The EN ISO approval is the internationally recognized European standard for quality control and management systems in the category of design and manufacture of…

WednesdayMar 10, 2021 9:36 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q4, Year-End Reports; Announces New CEO

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has released its financial numbers for the fourth quarter and fiscal year ended Dec. 31, 2020. Fourth-quarter revenue totaled $10.92 million, a 91% increase from quarter to quarter, with full-year revenue topping more than $24.5 million, a 120% increase year over year. In addition, Canadian cannabis revenue reached $8.5 million for the quarter, an increase of more than 120% over the previous quarter; that growth was supported by a substantial ramp up in production at the company’s Ancaster and Valleyfield facilities. The financial report…

WednesdayMar 10, 2021 8:59 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces FDA 510(k) Application for Exclusive Oral Appliance

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), recently submitted an application to the U.S. Food and Drug Administration (“FDA”) for its mmRNA (“mmRNA”) oral appliance(TM). The 510(k) Class II application focuses on the oral appliance as a treatment for mild-to-moderate OSA, sleep-disordered breathing and snoring in adults. The company’s oral appliance is an updated version of the company’s existing mRNA appliance(R), which previously received FDA clearance as a Class II oral appliance. The company noted that once it received approval for the…

TuesdayMar 09, 2021 3:38 pm

QualityStocksNewsBreaks – Green Hygienics Holdings Inc.’s (GRYN) Milestones Pave Path to Drive New Product Commercialization

Green Hygienics Holdings (OTCQB: GRYN) is dedicated to delivering the highest operating standards of industrial hemp cultivation and processing, as well as the manufacturing of pharmaceutical-grade bioactive cannabinoids. GRYN, with a commitment to becoming the most highly certified hemp company in the industry, is poised to bring safe and consistent products to market and thus change the industry’s landscape and enhance consumer confidence. Green Hygienics achieved important milestones in 2020 that lie at the heart of its value proposition and pave a research-based innovation path to drive new product commercialization fully compliant to USDA and FDA regulatory requirements. A recent…

Site Search

Company Search

Category: QualityStocksNewsBreaks